Galapagos NV (GLPG)
NASDAQ: GLPG · Real-Time Price · USD
32.26
+0.24 (0.75%)
At close: Sep 17, 2025, 4:00 PM EDT
32.26
0.00 (0.00%)
After-hours: Sep 17, 2025, 4:00 PM EDT
Galapagos NV Market Cap
Galapagos NV has a market cap or net worth of $2.11 billion as of September 17, 2025. Its market cap has increased by 7.59% in one year.
Market Cap
2.11B
Enterprise Value
-1.54B
1-Year Change
7.59%
Ranking
Category
Stock Price
$32.26
Market Cap Chart
Since May 14, 2015, Galapagos NV's market cap has increased from $1.86B to $2.11B, an increase of 13.24%. That is a compound annual growth rate of 1.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 2.11B | 16.43% |
| Dec 31, 2024 | 1.81B | -32.28% |
| Dec 29, 2023 | 2.68B | -8.14% |
| Dec 30, 2022 | 2.91B | -19.35% |
| Dec 31, 2021 | 3.61B | -43.56% |
| Dec 31, 2020 | 6.40B | -43.18% |
| Dec 31, 2019 | 11.27B | 141.07% |
| Dec 31, 2018 | 4.67B | 7.74% |
| Dec 29, 2017 | 4.34B | 72.91% |
| Dec 30, 2016 | 2.51B | 8.12% |
| Dec 31, 2015 | 2.32B | 24.52% |
| May 14, 2015 | 1.86B | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 686.51B |
| Johnson & Johnson | 424.98B |
| AbbVie | 382.04B |
| UnitedHealth Group | 307.73B |
| Novo Nordisk | 253.09B |
| AstraZeneca | 240.11B |
| Novartis AG | 237.94B |
| Abbott Laboratories | 231.06B |